Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 114
|
UKINETS2025
UKI NETS 23rd National Conference
All volumes
0114 UKINETS2025
0112 BES2025
0111 BSPED2025
0110 ECEESPE2025
0109 SFEBES2025
0108 NANETS2024
0107 IACS9
0106 BES2024
0105 UKINETS2024
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstracts
Abstract Book
Volume Editors
Contents
23rd National Conference of the UK and Ireland Neuroendocrine Tumour Society 2025
Oral Communications
Does surgical resection improve survival of pancreatic neuroendocrine tumours (panNET) less than 2 cm? a population-based study of 4,114 patients comparing England and the USA
ea0114oc1
Real-world outcomes for PRRT in patients with well differentiated gastroenteropancreatic neuroendocrine tumours
ea0114oc2
Impact of PRRT on quality of life in gastroenteropancreatic neuroendocrine tumours
ea0114oc3
Efficacy of somatostatin analogues versus other systemic therapies as first-line palliative treatment for patients with advanced, grade 2, well-differentiated neuroendocrine tumours of extra-pulmonary origin with a Ki-67 index between 10% and 20%
ea0114oc4
Poster Presentations
A qualitative study exploring the impact of gastrointestinal symptoms and malnutrition on the daily lives of patients living with neuroendocrine tumours (DIGEST)
ea0114p1
Exploring the impact of dietary interventions for people with NETs: a scoping review
ea0114p2
Sheffield teaching hospitals NHS foundation trust ENETS centre of excellence (ENETS COE) service evaluation of the inpatient 72-hour fasts for insulinoma: is continuous glucose monitoring the missing pre-test tool?
ea0114p3
De-novo versus transformed prostate neuroendocrine carcinoma: a population-based study of 1,326 patients
ea0114p4
Hemicolectomy or appendectomy for appendiceal neuroendocrine tumours sized 1-2 cm? a retrospective population-based study of 1,581 patients
ea0114p5
An update of the case controlled national pilot for liver transplantation in patients with neuroendocrine tumour (NETs) liver metastases between August 2021 and 31st July 2025
ea0114p6
Metastatic neuroendocrine tumour (NET) of the kidney: a case report
ea0114p7
Central mesenteric lymph node resection in stage 4 small intestine NET
ea0114p8
Demographic and clinical characteristics of patients undergoing surgery for pancreatic neuroendocrine tumours (PanNET): a retrospective population-based analysis of 11,934 patients comparing England and the USA
ea0114p9
Chemotherapy use and its effect on overall survival in gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN): a population based study of 63,911 patients
ea0114P10
Persistent Haematological Toxicity After PRRT in Neuroendocrine Tumours: A 10-Year Regional UK Experience
ea0114P11
Evaluation of the real-world use of hormone replacement therapy (HRT) in women with neuroendocrine cancers in sheffield teaching hospitals european neuroendocrine tumour centre of excellence
ea0114P12
Clinical risk factors for micronutrient deficiencies in patients with gastroenteropancreatic neuroendocrine tumours: a real-world evaluation
ea0114P13
A novel activating somatic EPAS1 variant in the hypoxia signalling pathway in a patient with paraganglioma and sickle cell disease
ea0114P14
Real-world survival outcomes following lutetium-177 dotatate PRRT in gastroenteropancreatic neuroendocrine tumours: a 138-patient UK experience
ea0114P15
Treatment of patients with low-grade neuroendocrine tumours: the impact of conventional chemotherapy on progression-free survival in low-grade gastroenteropancreatic neuroendocrine tumours
ea0114P16
Real-world outcomes of capecitabine and temozolomide in neuroendocrine tumours: a single-institution experience
ea0114P17
Case report: palliative radiotherapy in subcutaneous metastases from a neuroendocrine carcinoma
ea0114P18
Real world outcomes for patients with high grade neuroendocrine neoplasms at Guy's Cancer Centre
ea0114P19
Avoidable consequences of nutritional deficiencies: a case series of vitamin deficiencies secondary to neuroendocrine tumours and their treatment
ea0114P20
Late relapse of gastroenteropancreatic neuroendocrine tumours after curative resection: royal marsden experience
ea0114P21
Recurrence of cyclical ACTH-dependent cushing's syndrome secondary to thymic NET
ea0114P22
Special considerations in patients with neuroendocrine tumours referred for PRRT
ea0114P23
Copy number analysis through shallow whole genome sequencing of cell free DNA for neuroendocrine neoplasia monitoring
ea0114P24
Hypoglycaemia in later life: a case highlighting diagnostic and management challenges
ea0114P25
Relapse after resection of small bowel neuroendocrine tumours: frequency, time to relapse and post-relapse survival in a cohort of patients from the west yorkshire neuroendocrine tumour service. time to reconsider post-resection follow up?
ea0114P26
Case review - successful management of highly complex NET patients depends on the skills of MDTs
ea0114P27
Parathyroidectomy in multiple endocrine neoplasia patients: cohort analysis of clinical outcomes
ea0114P28
Outcomes of surgical resection for small bowel neuroendocrine tumors: a single-center recent experience
ea0114P29
Genetic susceptibility in metastatic adrenocortical carcinoma: a case-based insight
ea0114P30
Managing the crossroads of ectopic cushing's syndrome and sarcoidosis: a case report of multimodal therapeutic challenges
ea0114P31
AI-guided stratification of PRRT candidates: insights from current evidence and future directions
ea0114P32
Ai to flag SSTR imaging patterns predictive of poor PRRT outcomes
ea0114P33